Liminatus Pharma, Inc. - Class A Common Stock (NQ:LIMN)
Press Releases about Liminatus Pharma, Inc. - Class A Common Stock
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
September 29, 2026
Via GlobeNewswire
Via GlobeNewswire
Via GlobeNewswire
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
February 17, 2026
Via GlobeNewswire
Via GlobeNewswire
Via GlobeNewswire